An Enhanced Process to Reduce the Threat of Candida Auris in Acute Care Hospitals
This event has passed and can no longer be viewed
This event was presented live or live-streamed and has not been designated for on-demand presentation.
This Infection Prevention and Antimicrobial Stewardship Conference Series session will take place on Monday, March 25, 2024 at 12:00 p.m. Attendance will only be available remotely through Zoom.
Activity Information
Needs Statement
Infectious disease physicians, fellows, residents, medical students, advanced practice providers, and other healthcare professionals in the Texas Medical Center need to receive regular updates on advances in the field of infection prevention. The series will examine a wide range of topics, such as hospital-acquired infections, opportunistic infections, multi-drug antimicrobial resistance, and the principles of antimicrobial stewardship. The series also aims to expand the knowledge of learners, promote guideline-based infection prevention, enhance decision-making surrounding antibiotic usage, and improve patient outcomes.
Educational Objectives
At the conclusion of the sessions, the participants should be able to:
- Identify the methods to screen and isolate high-risk patients upon admission.
- Create a process to effectively decontaminate a room occupied by Candida auris patients.
- Develop strategies to mitigate a cluster outbreak of Candida auris.
Target Audience
Professional Categories
- Physicians
- Medical Students
- Fellows
- Residents
- Other Health Professionals
Specialties
- Infectious Disease
Interest Groups
- Hospital Medicine
Accreditation/Credit Designation
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Activity Director
-
Mayar Al Mohajer, M.D., MBA, MPH, FIDSA, FACHE
Vice Chair, QI and Innovations
Baylor College of Medicine
Disclosure Policy
Baylor College of Medicine (BCM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education (CME) for physicians. BCM is committed to sponsoring CE activities that are scientifically based, accurate, current, and objectively presented.
In accordance with the ACCME Standards for Commercial Support, BCM has implemented a mechanism requiring everyone in a position to control the content of an educational activity (i.e., directors, planning committee members, faculty) to disclose any relevant financial relationships with commercial interests (drug/device companies) and manage/resolve any conflicts of interest prior to the activity. Individuals must disclose to participants the existence or non-existence of financial relationships at the time of the activity or within 24 months prior.
In addition, BCM has requested activity faculty/presenters to disclose to participants any unlabeled use or investigational use of pharmaceutical/device products; to use scientific or generic names (not trade names) in referring to products; and, if necessary to use a trade name, to use the names of similar products or those within a class. Faculty/presenters have also been requested to adhere to the ACCME's validation of clinical content statements.
BCM does not view the existence of financial relationships with commercial interests as implying bias or decreasing the value of a presentation. It is up to participants to determine whether the relationships influence the activity faculty with regard to exposition or conclusions. If at any time during this activity you feel that there has been commercial/promotional bias, notify the Activity Director or Activity Coordinator. Please answer the questions about balance and objectivity in the activity evaluation candidly.
All of the relevant financial relationships listed for these individuals have been mitigated.
Disclosures
The following individual(s) has/have reported financial or other relationship(s) with commercial entities whose products/services may relate to the educational content of this activity:
Presenter
-
Janak A. Patel, M.D.
Director, Infection Control and Healthcare Epidemiology
University of Texas Medical Branch
Disclosure:
Nothing to disclose.
Activity Director
-
Mayar Al Mohajer, M.D., MBA, MPH, FIDSA, FACHE
Vice Chair, QI and Innovations
Baylor College of Medicine
Disclosure:
Nothing to disclose.
Planning Committee Members
-
Mayar Al Mohajer, M.D., MBA, MPH, FIDSA, FACHE
Vice Chair, QI and Innovations
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Prathit Kulkarni, M.D., FACP
Assistant Professor, Assistant Chief of Medicine, Associate Program Director of the Infectious Disease Fellowship
Baylor College of Medicine, Michael E. DeBakey VA Medical Center
Disclosure:
- Research Support (including clinical trials) & the principal or named investigator: Vessel Health, Inc.
-
Alison Robins, M.D.
Assistant Professor of Infectious Diseases
Baylor College of Medicine
Disclosure:
Nothing to disclose.
-
Edward Septimus, M.D., FACP
Adjunct Professor
Texas A&M College of Medicine
Disclosure:
Nothing to disclose.
-
Jesal Shah, M.D.
Infectious Diseases Fellow
Baylor College of Medicine
Disclosure:
Nothing to disclose.